The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Biodegradable dendrimers for drug delivery
Abstract
Dendrimers, as a type of artificial polymers with unique structural features, have been extensively explored for their applications in biomedical fields, especially in drug delivery. However, one important concern about the most commonly used dendrimers exists - the nondegradability, which may cause side effects induced by the accumulation of synthetic polymers in cells or tissues. Therefore, biodegradable dendrimers incorporating biodegradability with merits of dendrimers such as well-defined architectures, copious internal cavities and surface functionalities, are much more promising for developing novel nontoxic drug carriers. Herein, we review the recent advances in design and synthesis of biodegradable dendrimers, as well as their applications in fabricating drug delivery systems, with the aim to provide researchers in the related fields a good understanding of biodegradable dendrimers for drug delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Chen, C. Z., Beck-Tan, N. C., Dhurjati, P., van Dyk, T. K., LaRossa, R. A., & Cooper, S. L. (2000) · Biomacromolecules · doi:10.1021/bm0055495 · Cited by 443
Ph-responsive polymer–drug conjugates: design and progress
Pang, X., Jiang, Y., Xiao, Q., Leung, A. W., Hua, H., & Xu, C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.024 · Cited by 317
Biodendrimer-Based Hydrogel Scaffolds for Cartilage Tissue Repair
Söntjens, S. H. M., Nettles, D. L., Carnahan, M. A., Setton, L. A., & Grinstaff, M. W. (2006) · Biomacromolecules · doi:10.1021/bm050663e · Cited by 230
Oliveira, J. M., Salgado, A. J., Sousa, N., Mano, J. F., & Reis, R. L. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.006 · Cited by 182
Cited by
Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics
Kurian, A. G., Singh, R. K., Patel, K. D., Lee, J.-H., & Kim, H.-W. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.06.027 · Cited by 444
Biodegradable polymers and constructs: A novel approach in drug delivery
Prajapati, S. K., Jain, A., Jain, A., & Jain, S. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.08.018 · Cited by 308
De, R., Mahata, M. K., & Kim, K. (2022) · Advanced Science · doi:10.1002/advs.202105373 · Cited by 297
Wu, Y., Xie, Y., Liu, X., Li, Y., Wang, J., Chen, Z., Yang, H., Hu, B., Shen, C., Tang, Z., et al. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215097 · Cited by 296
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Zhu, Y., Liu, C., & Pang, Z. (2019) · Biomolecules · doi:10.3390/biom9120790 · Cited by 220
“With copious internal cavities and surface functionalities, dendritic materials have been considered as promising vehicles for specific drug delivery [19].”
BackgroundPharmaceutical nanotechnology: from the bench to the market
Mazayen, Z. M., Ghoneim, A. M., Elbatanony, R. S., Basalious, E. B., & Bendas, E. R. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00400-0 · Cited by 208
“Solubilization, gene therapy [38], dendrimer-based drug delivery [39], immunoassay, and MRI contrast agent are only a few of the uses for dendrimers.”
BackgroundWang, L., Li, Y., Ren, M., Wang, X., Li, L., Liu, F., Lan, Y., Yang, S., & Song, J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.008 · Cited by 91
Metadata
- Authors
- Huang, D., & Wu, D.
- Venue
- Materials Science and Engineering: C
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 90
- Pages
- 713-727
- ISSN
- 0928-4931 (ISSN-L)
- OpenAlex
- W2792608225
- Cited by
- 197
- References
- 5
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.